beta-lapachone has been researched along with Retinal Neovascularization in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SW | 1 |
| Kim, JH | 2 |
| Kim, KE | 1 |
| Jeong, MH | 1 |
| Park, H | 1 |
| Park, B | 1 |
| Suh, YG | 1 |
| Park, WJ | 1 |
1 other study available for beta-lapachone and Retinal Neovascularization
| Article | Year |
|---|---|
Beta-lapachone inhibits pathological retinal neovascularization in oxygen-induced retinopathy via regulation of HIF-1α.
Topics: Animals; Apoptosis; Astrocytes; Cell Hypoxia; Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, | 2014 |